[1] |
Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group[J]. N Engl J Med, 2000, 342(7):469-474.
|
[2] |
Liu Y, Zhu Y, Jiang C, et al. An electrochemical nitric oxide generator for in-home inhalation therapy in pulmonary artery hypertension[J]. BMC Med, 2022, 20(1):481.
|
[3] |
Kirbas A, Yalcin Y, Tanrikulu N, et al. Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery[J]. Cardiol J, 2012, 19(4):387-394.
|
[4] |
Liu K, Wang H, Yu SJ, et al. Inhaled pulmonary vasodilators: a narrative review[J]. Ann Transl Med, 2021, 9(7):597.
|
[5] |
Legrand M, Mebazaa A, Ronco C, et al. When cardiac failure, kidney dysfunction, and kidney injury intersect in acute conditions: the case of cardiorenal syndrome[J]. Crit Care Med, 2014, 42(9):2109-2017.
|
[6] |
Coutrot M, Dépret F, Legrand M. Is Nitric oxide nephro- or cardioprotective?[J]. Am J Respir Crit Care Med, 2019, 199(11):1441-1442.
|
[7] |
中华医学会小儿外科分会心脏学组, 国家儿童医学中心心血管专科联盟. 儿童先天性心脏病相关性肺高压诊断与治疗指南[J]. 中华小儿外科杂志, 2022, 43(11):966-980.
|
[8] |
Hopkins RA, Bull C, Haworth SG, et al. Pulmonary hypertensive crises following surgery for congenital heart defects in young children[J]. Eur J Cardiothorac Surg, 1991, 5(12):628-634.
|
[9] |
Hoskote A, Carter C, Rees P, et al. Acute right ventricular failure after pediatric cardiac transplant: predictors and long-term outcome in current era of transplantation medicine[J]. J Thorac Cardiovasc Surg, 2010, 139(1):146-153.
|
[10] |
Carmona MJ, Auler JO. Effects of inhaled nitric oxide on respiratory system mechanics, hemodynamics, and gas exchange after cardiac surgery[J]. J Cardiothorac Vasc Anesth, 1998, 12(2):157-161.
|
[11] |
Fullerton DA, Jones SD, Jaggers J, et al. Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation[J]. J Thorac Cardiovasc Surg, 1996, 111(4):753-763.
|
[12] |
Gianetti J, Del Sarto P, Bevilacqua S, et al. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation[J]. J Thorac Cardiovasc Surg, 2004, 127(1):44-50.
|
[13] |
Rich GF, Murphy GD, Roos CM, et al. Inhaled nitric oxide. selective pulmonary vasodilation in cardiac surgical patients[J]. Anesthesiology, 1993, 78(6):1028-1035.
|
[14] |
Morris K, Beghetti M, Petros A, et al. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease[J]. Crit Care Med, 2000, 28(8):2974-2978.
|
[15] |
Wessel DL, Adatia I, Giglia TM, et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass[J]. Circulation, 1993, 88(5 Pt 1):2128-2138.
|
[16] |
Turanlahti MI, Laitinen PO, Pesonen EJ. Preoperative and postoperative response to inhaled nitric oxide[J]. Scand Cardiovasc J, 2000, 34(1):46-52.
|
[17] |
Miller OI, Tang SF, Keech A, et al. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study[J]. Lancet, 2000, 356(9240):1464-1469.
|
[18] |
Yoshimura N, Yamaguchi M, Oka S, et al. Inhaled nitric oxide therapy after Fontan-type operations[J]. Surg Today, 2005, 35(1):31-35.
|
[19] |
Ma M, Gauvreau K, Allan CK, et al. Causes of death after congenital heart surgery[J]. Ann Thorac Surg, 2007, 83(4):1438-1445.
|
[20] |
Curran RD, Mavroudis C, Backer CL, et al. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension[J]. Ann Thorac Surg, 1995, 60(6):1765-1771.
|